425 related articles for article (PubMed ID: 31695789)
1. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
2. Hepatic peroxisome proliferator-activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice.
Piccinin E; Peres C; Bellafante E; Ducheix S; Pinto C; Villani G; Moschetta A
Hepatology; 2018 Mar; 67(3):884-898. PubMed ID: 28857232
[TBL] [Abstract][Full Text] [Related]
3. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
5. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.
Zhang S; Jiang T; Feng L; Sun J; Lu H; Wang Q; Pan M; Huang D; Wang X; Wang L; Jin H
J Mol Med (Berl); 2012 Sep; 90(9):1069-77. PubMed ID: 22391813
[TBL] [Abstract][Full Text] [Related]
6. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
Rong Z; Wang Z; Wang X; Qin C; Geng W
J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
[TBL] [Abstract][Full Text] [Related]
7. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
8. YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma.
Han J; Meng J; Chen S; Wang X; Yin S; Zhang Q; Liu H; Qin R; Li Z; Zhong W; Zhang C; Zhang H; Tang Y; Lin T; Gao W; Zhang X; Yang L; Liu Y; Zhou HG; Sun T; Yang C
Cancer Res; 2019 Apr; 79(7):1451-1464. PubMed ID: 30760518
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
10. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor.
Dong S; Ma X; Wang Z; Han B; Zou H; Wu Z; Zang Y; Zhuang L
Oncotarget; 2017 Jun; 8(25):40583-40593. PubMed ID: 28489564
[TBL] [Abstract][Full Text] [Related]
11. Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3.
Wang Y; Wu S; Huang C; Li Y; Zhao H; Kasim V
Cancer Sci; 2018 Aug; 109(8):2423-2434. PubMed ID: 29869834
[TBL] [Abstract][Full Text] [Related]
12. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.
Cunningham JT; Rodgers JT; Arlow DH; Vazquez F; Mootha VK; Puigserver P
Nature; 2007 Nov; 450(7170):736-40. PubMed ID: 18046414
[TBL] [Abstract][Full Text] [Related]
13. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.
Notarbartolo M; Giannitrapani L; Vivona N; Poma P; Labbozzetta M; Florena AM; Porcasi R; Muggeo VM; Sandonato L; Cervello M; Montalto G; D'Alessandro N
OMICS; 2011 May; 15(5):267-72. PubMed ID: 21332389
[TBL] [Abstract][Full Text] [Related]
14. HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.
Wang MD; Wu H; Huang S; Zhang HL; Qin CJ; Zhao LH; Fu GB; Zhou X; Wang XM; Tang L; Wen W; Yang W; Tang SH; Cao D; Guo LN; Zeng M; Wu MC; Yan HX; Wang HY
Oncotarget; 2016 Feb; 7(6):6711-26. PubMed ID: 26744319
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
[TBL] [Abstract][Full Text] [Related]
16. OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma.
Yang T; Liang N; Zhang J; Bai Y; Li Y; Zhao Z; Chen L; Yang M; Huang Q; Hu P; Wang Q; Zhang H
Metabolism; 2023 Oct; 147():155628. PubMed ID: 37315888
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
[TBL] [Abstract][Full Text] [Related]
18. Defects in long-chain 3-hydroxy acyl-CoA dehydrogenase lead to hepatocellular carcinoma: A novel etiology of hepatocellular carcinoma.
Khare T; Khare S; Angdisen JJ; Zhang Q; Stuckel A; Mooney BP; Ridenhour SE; Gitan RS; Hammoud GM; Ibdah JA
Int J Cancer; 2020 Sep; 147(5):1461-1473. PubMed ID: 32115688
[TBL] [Abstract][Full Text] [Related]
19. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
[TBL] [Abstract][Full Text] [Related]
20. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
